Literature DB >> 3881144

Plasmodium falciparum in vitro: diminished growth in hemoglobin H disease erythrocytes.

T C Ifediba, A Stern, A Ibrahim, R F Rieder.   

Abstract

Studies of the ability of Plasmodium falciparum to grow in vitro in the red blood cells of subjects with certain beta-thalassemia syndromes are often difficult to interpret because of the known inhibitory effect of an elevated cellular content of human fetal hemoglobin (HbF). P falciparum therefore was cultured in vitro in the erythrocytes of subjects with hemoglobin H (HbH) disease and various other alpha-thalassemia genotypes that are unaccompanied by increased levels of HbF. Growth of the malaria parasite was markedly retarded in HbH red blood cells, when compared with growth in blood from normal control subjects. No consistent impairment of growth was seen in the erythrocytes of subjects having deletion of only one or two alpha-globin genes. These results indicate that erythrocytes with a severe thalassemia phenotype provide a less hospitable growth environment for P falciparum than normally hemoglobinized red blood cells, even in the absence of increased levels of HbF.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3881144

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  Decreased sensitivity of artesunate and chloroquine of Plasmodium falciparum infecting hemoglobin H and/or hemoglobin constant spring erythrocytes.

Authors:  Y Yuthavong; P Butthep; A Bunyaratvej; S Fucharoen
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

2.  Epistatic interactions between genetic disorders of hemoglobin can explain why the sickle-cell gene is uncommon in the Mediterranean.

Authors:  Bridget S Penman; Oliver G Pybus; David J Weatherall; Sunetra Gupta
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-01       Impact factor: 11.205

Review 3.  The evolution of the alpha- and beta-globin gene clusters in human populations.

Authors:  A V Hill; J S Wainscoat
Journal:  Hum Genet       Date:  1986-09       Impact factor: 4.132

Review 4.  The role of the red blood cell in host defence against falciparum malaria: an expanding repertoire of evolutionary alterations.

Authors:  Morgan M Goheen; Susana Campino; Carla Cerami
Journal:  Br J Haematol       Date:  2017-08-23       Impact factor: 6.998

5.  Post-transfusion malaria in thalassaemia patients.

Authors:  N J Choudhury; M L Dubey; J G Jolly; A Kalra; R C Mahajan; N K Ganguly
Journal:  Blut       Date:  1990-11

6.  Thalassemic erythrocytes inhibit in vitro growth of Plasmodium falciparum.

Authors:  C R Brockelman; B Wongsattayanont; P Tan-ariya; S Fucharoen
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

7.  Artemisinin Therapy for Malaria in Hemoglobinopathies: A Systematic Review.

Authors:  Sri Riyati Sugiarto; Brioni R Moore; Julie Makani; Timothy M E Davis
Journal:  Clin Infect Dis       Date:  2018-02-10       Impact factor: 9.079

8.  Resistance to artemisinin of malaria parasites (Plasmodium falciparum) infecting alpha-thalassemic erythrocytes in vitro. Competition in drug accumulation with uninfected erythrocytes.

Authors:  S Kamchonwongpaisan; G Chandra-ngam; M A Avery; Y Yuthavong
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

9.  Protection against malaria morbidity: near-fixation of the alpha-thalassemia gene in a Nepalese population.

Authors:  G Modiano; G Morpurgo; L Terrenato; A Novelletto; A Di Rienzo; B Colombo; M Purpura; M Mariani; S Santachiara-Benerecetti; A Brega
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

10.  Effects of thalassaemic serum on the in vitro development of the malarial parasite Plasmodium falciparum.

Authors:  B W Thanomsub; S Fucharoen; C R Brockelman; J Bhisutthibhan
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.